Exogenous repletion of Gpx‐1 with compounds like ebselen may have therapeutic potential in not only treating the pulmonary manifestations of COPD but perhaps its cardiovascular co‐morbidities. Here, GPX1 is linked to chronic obstructive pulmonary disease.